International Stem Cell Corporation’s Human Parthenogenetic Stem Cells To Be Used In Germany In The Development Of Treatments For Neural Disease

International Stem Cell Corporation (OTCBB:ISCO) announced that its human parthenogenetic stem cell lines will be used in Germany in studies aimed at creating specific cell types to treat human neural diseases such as Parkinson’s disease. The work will be headed by Dr. Albrecht Mueller of the University of Wuerzburg, Wuerzburg, Germany under a Material Transfer Agreement between International Stem Cell Corporation (ISCO) and the University of Wuerzburg. “The fact that Dr.

More: continued here

Filed under: Parkinson's Disease on March 3rd, 2008